Several of the world’s largest medical device makers warned investors that the COVID-19 outbreak has delayed and in some cases halted elective medical procedures — and that will likely cut into their earnings for the quarter.
Their stock prices have increased faster than the S&P; 500 Continue reading...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces its newly launched OR3O Dual Mobility System for total hip arthroplasty (THA) has received encouraging results from early surgeon experience. Utilizing proprietary OXINIUM™ DH Technology, the OR3O system offers the benefits of dual mobility - increased range of motion and "jump distance"1* – while also incorporating unique material advantages.
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a strategic partnership with St. Louis-based National Medical Billing Services (National Medical) to provide revenue cycle management (RCM) solutions to Ambulatory Surgery Centers (ASCs) across the US.
Smith & Nephew plc (LON:SN.) stock is about to trade ex-dividend in 2 days time. This means that investors who...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces 'Positive Connections', a turnkey service to support healthcare providers seeking to offer increased access for orthopaedic cases to Ambulatory Surgery Centers (ASCs) and other outpatient settings.
Will the new coronavirus cause a recession in US in the next 6 months? On February 27th, we put the probability at 75% and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to […]
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the US launch of the new PICO 14 Single Use Negative Pressure Wound Therapy System (sNPWT) which has a pump duration of up to 14 days.1 The new pump builds on the features and advantages of previous PICO sNPWT variants, and comes with an enhanced pump which requires less user intervention.2*
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce the market introduction and first commercial procedure of its Tula System – an in-office solution for placement of tympanostomy tubes (commonly known as ear tubes).
We are upbeat about Abbott's (ABT) strong and consistent EPD and Medical Devices performances, organically.
Image source: The Motley Fool. Smith & Nephew plc (NYSE: SNN)Q1 2020 Earnings CallMay 6, 2020, 3:30 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator[Starts Abruptly] Certain statements in this presentation are forward-looking statements.
NEW YORK, NY / ACCESSWIRE / February 20, 2020 / Smith & Nephew Plc (NYSE:SNN) will be discussing their earnings results in their 2019 Second Half Earnings call to be held on February 20, 2020 at 4:00 AM ...
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the launch of its new JOURNEY II Unicompartmental Knee (UK) System. Built on the heritage of one of the most clinically successful partial knees,1,2 and paired with proprietary OXINIUM™ Technology, JOURNEY II UK is designed to help patients rediscover their normal life.
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
Fiagon, a technology leader who develops and manufactures innovative surgical image guidance technologies, announced today a partnership with Smith+Nephew (NYSE: SNN, LSE: SN), a global medical technology business, to distribute its ENT surgical navigation portfolio in the Asia Pacific Asean region. This agreement covers China, the India subcontinent, Australia, New Zealand, and other ASEAN markets.
Examining Smith & Nephew plc's (LSE:SN.) past track record of performance is a useful exercise for investors. It...
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces an agreement with Fiagon – a technology leader in electromagnetic surgical navigation solutions – to distribute its ENT portfolio in the Asia Pacific region. This agreement covers China, India subcontinent, Australia, New Zealand, and ASEAN markets.
If you own shares in Sunniva Inc. (CSE:SNN) then it's worth thinking about how it contributes to the volatility of...
Some hospitals in the U.S. are already canceling or postponing elective medical appointments and procedures as they prepare for the possibility of a surge in COVID-19 patients.
Scientists are excited about the potential for artificial intelligence, improved connectivity, and other technological advancements to make robotic surgery more accurate and accessible.